Follow The Filings

KLRA position history

The shares of Kailera Therapeutics (KLRA) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COMMON STOCK

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q2: 1,100,000 shares, $24M, 0.11% of portfolio, New
Holdings date Value % of holdings Shares Filing date All 13F holders